Authors: Cannon, CP McCabe, CH Wilcox, RG Langer, A Caspi, A Berink, P Lopez-Sendon, J Toman, J Charlesworth, A Anders, RJ Alexander, JC Skene, A Braunwald, E

Citation: Cp. Cannon et al., Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial, CIRCULATION, 102(2), 2000, pp. 149-156